The purpose of this study was to investigate whether an association exists between the promoter region of 
Introduction
Essential hypertension (EH) is a common disorder of multifactorial origin. However, it is not clear if genetic variants influence the development of this disease. It has been reported that cerebrovascular infarctions resulting from complications of atherosclerosis are associated with disturbances in microcirculatory flow caused by intravascular platelet activation (1) .
Prostacyclin inhibits platelet aggregation, smooth muscle cell proliferation, and vasoconstriction (2 -4) . Prostacyclin synthase (EC 5.3.99.4), which catalyzes the formation of prostacyclin from prostaglandin H2, is widely distributed,
Methods

Subjects
The study group consisted of 200 patients (mean age 53. 6 11.1 years) with EH diagnosed according to WHO criteria, which included a sitting systolic blood pressure (SBP) of more than 160 mmHg and/or diastolic blood pressure (DBP) of more than 95 mmHg on three occasions spanning 2 months from the first medical examination (Table 1 ) (10). These patients were not being treated with anti-hypertensive drugs. Subjects diagnosed with secondary hypertension were excluded. Two hundred normotensive (NT) healthy subjects (mean age 53.2 10.9 years) were also studied as controls. The normotensive subjects had no family history of hypertension, and in all cases their SBP was less than 140 mmHg and their DBP less than 85 mmHg. A positive family history was defined as prior diagnosis of hypertension in grandparents, uncles, aunts, parents, or siblings. Informed consent was obtained from each individual according to a protocol approved by the Ethics Committee of the Nihon University School of Medicine and the Clinical Studies Committee of Nihon University Hospital.
Biochemical Analysis
The plasma concentration of total cholesterol and the serum concentrations of creatinine and uric acid were measured by standard methods in the Clinical Laboratory Department of Nihon University Hospital (11) .
Single Strand Conformation Polymorphism
DNA was extracted from whole blood according to standard procedures (12) . For single-strand conformation polymorphism (SSCP) analysis, two oligonucleotide primers were designed for the (5 -ACATTTTCCCCCAGGCCTGAGCTGC-3 , sense) and (5 -CGGCTCAGTAGCAGCAGCAGCAACAG T-3 , antisense) genomic sequences of the prostacyclin synthase gene (7) . Polymerase chain reaction (PCR) products were subjected to analysis on 5% nondenaturing acrylamide gels at 25ºC with 5% glycerol and at 4ºC without glycerol (9) .
Sequencing Analysis
PCR products showing an abnormally migrating band and normal controls were gel purified and subjected to automated DNA sequencing analyses with fluorescence-labeled dideoxyterminators (ABI PRISM Dye Terminator Cycle Sequencing Ready Reaction Kit; Perkin Elmer, Norwalk, USA) according to the manufacturer's instructions (ABI PRISM 310 Genetic Analyzer; PE Applied Biosystems, Foster City, USA) (13) . Sequencing was performed for both strands.
Genotyping
Genotyping was confirmed by the sequencing and PCR-SS CP analysis.
Statistical Analysis
Data are shown as the mean SD. Allele frequencies were calculated from the genotypes of all subjects. Hardy-Weinberg equilibrium was assessed by χ 2 analysis. The overall distribution of genotypes was analyzed by 2 3 contingency tables, and a p value of less than 0.05 was considered significant. Individual differences in allele frequencies were tested using 2 2 contingency tables for each allele, and a p value of less than 0.05 was considered significant. 
Results
Using SSCP, we discovered a single nucleotide polymorphism (SNP) positioned 192 nucleotides from the start codon (Fig. 1) . We genotyped 200 EH and 200 NT individuals. The estimated allele frequencies are shown in Table 2 . The observed and expected genotypes in the NT group were in good agreement with the predicted Hardy-Weinberg equilibrium values ( χ 2 0.296, df 1, p 0.59). The overall distributions of the genotypes ( χ 2 0.72, df 2, p 0.70) and alleles ( χ 2 0.10, df 1, p 0.75) were not significantly different between the EH patients and the NT subjects. The overall distributions of the genotypes and alleles in men and women were not significantly different between the EH patients and the NT subjects ( Table 2) .
The genotyping of this SNP and variable number of tandem repeat (VNTR) upstream of the translational initiation codon (14) in NT subjects revealed that the SNP showed no linkage with the VNTR in the promoter region (Table 3) .
Discussion
We previously identified a nonsense mutation in exon 2 of the human prostacyclin synthase gene in a family with a history of cerebral infarction and EH (9) . This mutation was found in only 1 woman out of 300 subjects comprising 150 EH and 150 NT individuals. This suggested that prostacyclin synthase gene abnormalities may be associated with EH. We hypothesized that a genetic variant with a functional differ- ence could be linked to EH even if its frequency in the population was very low. The presence of genetic heterogeneity, however, makes prediction of the degrees of overlap between many genes in a population difficult. Our study suggests that the differences in prostacyclin activities are alleledependent, and these differences may influence the risk of EH.
Recently, we isolated a VNTR polymorphism 6 bp upstream of the ATG start codon of this gene and showed that the VNTR was associated with a risk of cerebral infarction (14) but not with EH (15) . Furthermore, each allele of the prostacyclin synthase gene has a different transcriptional activity. Alleles with smaller numbers of tandem repeats have lower transcriptional activity. The region between 150 and the start codon is GC-rich, and it has been reported that this position contains the basal promoter region (7). These experiments suggested that the VNTR may influence the basic transcriptional activity, and that the influence of PGIS may be stronger for cerebral infarction than for EH. Iwai et al. (16) reported that the alleles of the 3 and 4 repeat of this polymorphism seem to be a risk factor for higher pulse pressure and systolic hypertension. This is consistent with our result that hypertension is one of the risk factors of cerebral infarction. Chevalier et al. (17) also reported this VNTR polymorphism independently. However, neither of these investigators reported the SNP.
In the present study, we found a novel SNP in the 5 -flanking region of the prostacyclin synthase gene. This SNP shows no linkage with the VNTR in the promoter region. Although the current SNP is also present in the 5 -flanking region of this gene, association analysis did not reveal a significant difference between the allele frequencies with respect to EH. Because the position of this SNP, 192, is somewhat distanced from the region having the basic transcriptional activity, it may be that this SNP has no influence on the transcriptional activity. This polymorphism is thus not a useful marker for studying the relation between the PGIS gene and EH in the Japanese population.
